Cargando…

Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it

Most of the evidences for beneficial effects of beta-blockers in patients with acute myocardial infarction (AMI) were from the clinical studies published in the pre-reperfusion era when anti-platelet drugs, statins or inhibitors of renin-angiotensin-aldosterone system which are known to reduce cardi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Joo, Seung-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Critical Care Medicine 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497890/ https://www.ncbi.nlm.nih.gov/pubmed/37652855 http://dx.doi.org/10.4266/acc.2023.00955

Ejemplares similares

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
por: Giannakopoulos, Georgios, et al.
Publicado: (2021)

Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
por: Hu, Mengjin, et al.
Publicado: (2022)

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction
por: Ferreira, João André, et al.
Publicado: (2021)

Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction
por: Joo, Seung-Jae, et al.
Publicado: (2022)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction
por: Zhong, Yue, et al.
Publicado: (2017)

Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
por: Kezerashvili, Anna, et al.
Publicado: (2012)

Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
por: Lee, Jae-Geun, et al.
Publicado: (2023)

Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization
por: Sim, Hui Wen, et al.
Publicado: (2020)

Clinical Impact of Beta Blockers in Patients with Myocardial Infarction from the Korean National Health Insurance Database
por: Won, Hoyoun, et al.
Publicado: (2020)

One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction
por: Goldberger, Jeffrey J., et al.
Publicado: (2021)

Effect of β-Blockers on the Risk of Atrial Fibrillation in Patients with Acute Myocardial Infarction
por: Pesaro, Antonio Eduardo, et al.
Publicado: (2010)

Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction
por: Kim, Jihoon, et al.
Publicado: (2023)

Beta-Blockers for the Secondary Prevention of Myocardial Infarction in People with Dementia: A Systematic Review
por: Lanham, David, et al.
Publicado: (2019)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
por: Amino, Mari, et al.
Publicado: (2021)

Myocardial strain to identify benefit from beta‐blockers in patients with heart failure with reduced ejection fraction
por: Park, Chan Soon, et al.
Publicado: (2022)

Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
por: Chung, Jaehoon, et al.
Publicado: (2017)

Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction
por: Park, Jin Joo, et al.
Publicado: (2018)

Topical beta‐blockers in dermatologic therapy
por: Filoni, Angela, et al.
Publicado: (2021)

Comparative Effectiveness of Long‐Term Maintenance Beta‐Blocker Therapy After Acute Myocardial Infarction in Stable, Optimally Treated Patients Undergoing Percutaneous Coronary Intervention
por: Lee, Myunhee, et al.
Publicado: (2023)

The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic
por: Olmastroni, Elena, et al.
Publicado: (2022)

Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry
por: Chung, Jaehoon, et al.
Publicado: (2021)

Due caution using early β-blockers for acute myocardial infarction
por: McKee, Scott, et al.
Publicado: (2007)

Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction
por: Hioki, Hirofumi, et al.
Publicado: (2015)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
por: Desta, Liyew, et al.
Publicado: (2020)

The duration of beta‐blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study
por: Wen, Xue‐Song, et al.
Publicado: (2022)

Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy
por: Slart, R. H. J. A., et al.
Publicado: (2010)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Al-Jabari, Ali Mohammed Kareem, et al.
Publicado: (2017)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction
por: Lee, Jang Hoon, et al.
Publicado: (2016)

Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
por: Haddiya, Intissar, et al.
Publicado: (2023)

Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed Medication
por: Pedersen, Susanne Bendesgaard, et al.
Publicado: (2016)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9ekl3lol5enamsjh9p40otgqsb